Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating the interaction between neurons and glial cells, will present the Phase II results of its drug candidate THN102...
AMOEBA (FR0011051598 – AMEBA), – producer of a biological biocide capable of eliminating the risk in water and human wounds, and of a biocontrol product for plant protection, still in the testing phase, announces that the results of the second field trials...
AMOEBA (FR0011051598 – AMEBA) – producer of a biological biocide capable of eliminating the risk in water and human wounds, and of a biocontrol product for plant protection, still in the testing phase, announces the first efficacy results of its biocontrol...
Recent Comments